… TIDES Europe - Oligonucleotide and Peptide Therapeutics Conference ProQR to present at the TIDES Europe conference on oligonucleotide and peptide therapeutics in … 11/18/2022 - 23:59 ProQR to present at the TIDES Europe conference on oligonucleotide and peptide therapeutics in …
… technology was introduced at the Company’s second annual Research & Development Investor Day and in vivo proof of … F508del mutation were presented at the North American CF conference. A Phase 2 study is currently being designed and … QR-313 pre-clinical data were presented at the EB2017 ResearchConference and ESDR meeting. IND-enabling studies …